• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨癌种 TRP 家族与肿瘤微环境相互作用与预后和免疫治疗反应相关的全景图。

The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.

机构信息

Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, China.

Cardiothoracic Surgery Department, Affiliated Hospital of Nantong University, Nantong, China.

出版信息

Front Immunol. 2022 Apr 13;13:837665. doi: 10.3389/fimmu.2022.837665. eCollection 2022.

DOI:10.3389/fimmu.2022.837665
PMID:35493463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9043495/
Abstract

BACKGROUND

Transient Receptor Potential (TRP) channel is a kind of channel protein widely distributed in peripheral and central nervous system. They can be regulated by natural aromatic substances and serve as a therapeutic target for many diseases. However, the role and function of the TRP family genes in tumours remain unclear.

METHODS

Gene alterations (mutation, copy number, methylation), expression, clinical features, and prognostic value of the TRP family genes were evaluated in pan-cancer using data from The Cancer Genome Atlas and Genotype-Tissue Expression databases. TRP score was calculated by the ssGSEA function of the R package "GSVA". The association of TRP score and the tumour microenvironment (TME), especially the tumour immune microenvironment (TIME), along with immunotherapy response were explored in-depth.

RESULTS

TRP family genes were involved in tumour progression and highly associated with poor prognosis in a variety of cancers. TRP score was positively associated with malignant pathways in pan-cancer, such as IL6-JAK-STAT3 signalling, interferon-gamma response, and inflammatory response. All pathways were closely associated with TIME. Elevated TRP score also correlated with multiple immune-related characteristics of the TIME in pan-cancer. Moreover, the TRP score was a predictive biomarker for immune checkpoint inhibitor (ICI) treatments in patients with tumours.

CONCLUSIONS

TRP family genes play a key role in pan-cancer and are closely associated with TME. Patients with high TRP scores have excellent immune-activated TIME and immunotherapy sensitivity. Therefore, the TRP score could be a potential biomarker for patients with tumours treated with ICI.

摘要

背景

瞬时受体电位 (TRP) 通道是一种广泛分布于外周和中枢神经系统的通道蛋白。它们可以被天然芳香物质调节,作为许多疾病的治疗靶点。然而,TRP 家族基因在肿瘤中的作用和功能尚不清楚。

方法

使用来自癌症基因组图谱和基因型组织表达数据库的数据,评估 TRP 家族基因在泛癌中的基因改变(突变、拷贝数、甲基化)、表达、临床特征和预后价值。通过 R 包“GSVA”的 ssGSEA 功能计算 TRP 评分。深入探讨 TRP 评分与肿瘤微环境(TME),特别是肿瘤免疫微环境(TIME)的关系,以及与免疫治疗反应的关系。

结果

TRP 家族基因参与肿瘤的进展,并与多种癌症的不良预后高度相关。TRP 评分与泛癌中的恶性途径呈正相关,如 IL6-JAK-STAT3 信号通路、干扰素-γ反应和炎症反应。所有途径都与 TIME 密切相关。升高的 TRP 评分还与泛癌中 TIME 的多个免疫相关特征相关。此外,TRP 评分是预测肿瘤患者免疫检查点抑制剂 (ICI) 治疗效果的生物标志物。

结论

TRP 家族基因在泛癌中发挥关键作用,与 TME 密切相关。TRP 评分高的患者具有出色的免疫激活 TIME 和免疫治疗敏感性。因此,TRP 评分可能是接受 ICI 治疗的肿瘤患者的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/69544de9d0f5/fimmu-13-837665-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/30b282d2948d/fimmu-13-837665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/19987f8b60c4/fimmu-13-837665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/c46d7b3c0079/fimmu-13-837665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/aa18d89e128a/fimmu-13-837665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/15d811c4607a/fimmu-13-837665-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/897397845dfd/fimmu-13-837665-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/a18046f47ccf/fimmu-13-837665-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/d1d1961a4315/fimmu-13-837665-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/9e7d1f98f6e8/fimmu-13-837665-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/e0930341b276/fimmu-13-837665-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/12811cda1d6e/fimmu-13-837665-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/c0251985c887/fimmu-13-837665-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/3ed636e234ce/fimmu-13-837665-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/69544de9d0f5/fimmu-13-837665-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/30b282d2948d/fimmu-13-837665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/19987f8b60c4/fimmu-13-837665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/c46d7b3c0079/fimmu-13-837665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/aa18d89e128a/fimmu-13-837665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/15d811c4607a/fimmu-13-837665-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/897397845dfd/fimmu-13-837665-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/a18046f47ccf/fimmu-13-837665-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/d1d1961a4315/fimmu-13-837665-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/9e7d1f98f6e8/fimmu-13-837665-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/e0930341b276/fimmu-13-837665-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/12811cda1d6e/fimmu-13-837665-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/c0251985c887/fimmu-13-837665-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/3ed636e234ce/fimmu-13-837665-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e755/9043495/69544de9d0f5/fimmu-13-837665-g014.jpg

相似文献

1
The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.跨癌种 TRP 家族与肿瘤微环境相互作用与预后和免疫治疗反应相关的全景图。
Front Immunol. 2022 Apr 13;13:837665. doi: 10.3389/fimmu.2022.837665. eCollection 2022.
2
Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity.泛癌症分析 TRP 家族,特别是 TRPV4 和 TRPC4,及其表达与预后、肿瘤微环境和治疗敏感性的相关性。
Biomolecules. 2023 Feb 2;13(2):282. doi: 10.3390/biom13020282.
3
The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.FOXO 家族与临床结局和耐药性相关的泛癌多组学全景。
Int J Mol Sci. 2022 Dec 9;23(24):15647. doi: 10.3390/ijms232415647.
4
Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.YBX家族的全癌综合分析揭示YBX2作为肝癌的潜在生物标志物。
Front Immunol. 2024 Apr 18;15:1382520. doi: 10.3389/fimmu.2024.1382520. eCollection 2024.
5
The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer.血管生成和重塑(AR)相关特征在预测免疫治疗泛癌患者预后和临床结局中的作用。
Front Immunol. 2022 Nov 21;13:1033967. doi: 10.3389/fimmu.2022.1033967. eCollection 2022.
6
Immunological role and prognostic value of the SKA family in pan-cancer analysis.SKA 家族在泛癌分析中的免疫作用和预后价值。
Front Immunol. 2023 Apr 26;14:1012999. doi: 10.3389/fimmu.2023.1012999. eCollection 2023.
7
IP-score correlated to endogenous tumour antigen peptide processing: A candidate clinical response score algorithm of immune checkpoint inhibitors therapy in multiple cohorts.IP 评分与内源性肿瘤抗原肽加工相关:免疫检查点抑制剂治疗多个队列的候选临床反应评分算法。
Front Immunol. 2023 Jan 9;13:1085491. doi: 10.3389/fimmu.2022.1085491. eCollection 2022.
8
Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.泛癌症分析 AIM2 炎性体,对人类癌症的免疫治疗具有潜在意义:批量组学研究和单细胞测序验证。
Front Immunol. 2022 Sep 29;13:998266. doi: 10.3389/fimmu.2022.998266. eCollection 2022.
9
Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.泛癌症分析揭示白细胞介素-17 家族成员可作为免疫检查点抑制剂疗效预测的生物标志物。
Front Immunol. 2022 Sep 8;13:900273. doi: 10.3389/fimmu.2022.900273. eCollection 2022.
10
The circadian rhythm key gene : a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers.昼夜节律关键基因:一种新型的预后生物标志物,用于鉴定人类癌症中的免疫抑制性肿瘤微环境和预测免疫治疗效果。
Front Immunol. 2023 May 19;14:1115809. doi: 10.3389/fimmu.2023.1115809. eCollection 2023.

引用本文的文献

1
Coptisine ameliorates colitis in mice by modulating cPLA2/TRPM8/CGRP-1 signaling pathways and strengthening intestinal barrier function.黄连碱通过调节cPLA2/TRPM8/CGRP-1信号通路和增强肠道屏障功能来改善小鼠结肠炎。
Braz J Med Biol Res. 2025 Mar 3;58:e14349. doi: 10.1590/1414-431X2025e14349. eCollection 2025.
2
Recent advancement of sonogenetics: A promising noninvasive cellular manipulation by ultrasound.声遗传学的最新进展:一种通过超声进行的有前景的非侵入性细胞操作。
Genes Dis. 2023 Sep 15;11(5):101112. doi: 10.1016/j.gendis.2023.101112. eCollection 2024 Sep.
3
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers.

本文引用的文献

1
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.弥漫性胶质瘤中的肿瘤突变负荷、表达的新抗原与免疫微环境
Cancers (Basel). 2021 Dec 3;13(23):6092. doi: 10.3390/cancers13236092.
2
Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway.溶酶体膜钙离子通道蛋白 1(MCOLN1)/跨膜通道样蛋白 1(TRPML1)介导向性自噬抑制通过调控活性氧(ROS)诱导的 TP53/p53 通路抑制癌症转移。
Autophagy. 2022 Aug;18(8):1932-1954. doi: 10.1080/15548627.2021.2008752. Epub 2021 Dec 8.
3
Therapeutic potential of TRPM8 antagonists in prostate cancer.
细胞周期蛋白依赖性激酶16(CDK16)作为一种潜在的预后生物标志物,与免疫抑制性肿瘤微环境相关,且有助于提高人类癌症免疫治疗的效果。
Aging (Albany NY). 2024 Jan 22;16(2):1879-1896. doi: 10.18632/aging.205465.
4
Transient receptor potential-related risk model predicts prognosis of hepatocellular carcinoma patients.瞬时受体电位相关风险模型预测肝细胞癌患者的预后。
World J Gastrointest Oncol. 2023 Dec 15;15(12):2064-2076. doi: 10.4251/wjgo.v15.i12.2064.
5
M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma.M2 巨噬细胞抑制仑伐替尼对肝内胆管癌的抗肿瘤作用。
Front Immunol. 2023 Sep 22;14:1251648. doi: 10.3389/fimmu.2023.1251648. eCollection 2023.
6
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.新的遗传和表观遗传对趋化因子系统的深入了解:最新发现有助于朝着精准医学迈进。
Cell Mol Immunol. 2023 Jul;20(7):739-776. doi: 10.1038/s41423-023-01032-x. Epub 2023 May 17.
7
Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma.用于预测肺腺癌总生存期的TRP相关基因特征的开发与验证
Front Genet. 2022 Sep 15;13:905650. doi: 10.3389/fgene.2022.905650. eCollection 2022.
8
Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma.肺腺癌中TRP相关基因分子亚型的系统分析、鉴定及预后预测
J Oncol. 2022 Aug 31;2022:5388283. doi: 10.1155/2022/5388283. eCollection 2022.
TRPM8 拮抗剂在前列腺癌中的治疗潜力。
Sci Rep. 2021 Dec 1;11(1):23232. doi: 10.1038/s41598-021-02675-4.
4
Identification of TRPV4 as a novel target in invasiveness of colorectal cancer.鉴定 TRPV4 为结直肠癌侵袭的一个新靶点。
BMC Cancer. 2021 Nov 23;21(1):1264. doi: 10.1186/s12885-021-08970-7.
5
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma.免疫细胞图谱预测 PD-1 阻断治疗皮肤 T 细胞淋巴瘤的反应。
Nat Commun. 2021 Nov 18;12(1):6726. doi: 10.1038/s41467-021-26974-6.
6
A functional study for verifying the pathogenicity of a TRPM6 variant of uncertain significance: A novel non-canonical splicing-site variant in primary hypomagnesemia with secondary hypocalcemia.验证意义未明的TRPM6变异体致病性的功能研究:原发性低镁血症伴继发性低钙血症中的一种新型非经典剪接位点变异体。
Clin Chim Acta. 2021 Dec;523:469-475. doi: 10.1016/j.cca.2021.10.033. Epub 2021 Oct 28.
7
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.免疫治疗肝细胞癌患者的预后——CRAFITY 评分的建立和验证。
J Hepatol. 2022 Feb;76(2):353-363. doi: 10.1016/j.jhep.2021.09.035. Epub 2021 Oct 12.
8
Advances in TRP channel drug discovery: from target validation to clinical studies.TRP 通道药物发现的进展:从靶点确证到临床研究。
Nat Rev Drug Discov. 2022 Jan;21(1):41-59. doi: 10.1038/s41573-021-00268-4. Epub 2021 Sep 15.
9
TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs.瞬时受体电位香草酸亚型4(TRPV4)是一种预后生物标志物,与免疫抑制微环境和抗癌药物的化疗耐药性相关。
Front Mol Biosci. 2021 Jun 28;8:690500. doi: 10.3389/fmolb.2021.690500. eCollection 2021.
10
TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.作为乳腺癌新治疗靶点的瞬时受体电位通道相互作用组
Front Oncol. 2021 Jun 10;11:621614. doi: 10.3389/fonc.2021.621614. eCollection 2021.